Key Insights

Highlights

Success Rate

81% trial completion

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 72/100

Termination Rate

12.5%

3 terminated out of 24 trials

Success Rate

81.3%

-5.3% vs benchmark

Late-Stage Pipeline

8%

2 trials in Phase 3/4

Results Transparency

38%

5 of 13 completed with results

Key Signals

5 with results81% success

Data Visualizations

Phase Distribution

21Total
Not Applicable (16)
P 1 (1)
P 2 (2)
P 4 (2)

Trial Status

Completed13
Unknown5
Terminated3
Not Yet Recruiting1
Withdrawn1
Recruiting1

Trial Success Rate

81.3%

Benchmark: 86.5%

Based on 13 completed trials

Clinical Trials (24)

Showing 20 of 20 trials
NCT07265505Not ApplicableNot Yet Recruiting

Study of Endometrial Immune and Microbiological Modifications in Cases of Recurrent Implantation Failure and/or Recurrent Pregnancy Loss

NCT06936475Not ApplicableCompletedPrimary

Vaginal Cleansing With Chlorhexidine Versus Iodine for Prevention of Endometritis

NCT04307069Not ApplicableRecruiting

Management of Prelabor Rupture of the Membranes at Term

NCT04197167Not ApplicableUnknownPrimary

Mid-Infrared Spectroscopy as a Real Time Diagnostic Tool for Chronic Endometritis

NCT04163679Not ApplicableTerminated

Vaginal Preparation and Azithromycin to Reduce Post Cesarean Infections

NCT05049395Not ApplicableUnknownPrimary

HFNO Reducing the Incidence of Hypoxia for Hysteroscopy Sedated With Propofol

NCT02402907Not ApplicableCompleted

STRIPES Study: Study To Reduce Infection Post cEsarean Section

NCT03442218Not ApplicableCompleted

Use of Antiseptic Solution for Vaginal Wash Before Cesarean Section

NCT03960970Phase 2UnknownPrimary

Two-drug Antibiotic Prophylaxis in Scheduled Cesarean Deliveries

NCT03459599Not ApplicableCompleted

Antibiotic Prophylaxis in Ragged Placental Membranes

NCT01235546Not ApplicableCompletedPrimary

Study of Effectiveness and Safety of Azithromycin-based Extended-spectrum Prophylaxis to Prevent Post Cesarean Infection

NCT01464840CompletedPrimary

The Pharmacokinetics of Azithromycin Prophylaxis for Cesarean Delivery

NCT00603603Not ApplicableCompleted

Controlled Clinical Trial of Supplemental Oxygen for the Prevention of Post-Cesarean Infectious Morbidity

NCT02742948Phase 2UnknownPrimary

The Optimal Time for Intravenous Antibiotic Prophylaxis in Elective Cesarean Section

NCT01762098Completed

Chronic Endometritis in Patients With Recurrent Miscarriages or Repeated Implantation Failures in In-vitro Fertilization

NCT01587495Phase 1TerminatedPrimary

Pharmacokinetics and Safety of Ertapenem in the Postpartum Period

NCT01721616Phase 4WithdrawnPrimary

Comparison Study of Cefazolin Versus Cefazolin Plus Azithromycin Prophylaxis in Post-Cesarean Endometritis

NCT01945450Not ApplicableUnknownPrimary

Prophylactic Antibiotics for Manual Removal of Retained Placenta in Vaginal Birth: a Randomized Controlled Trial

NCT00858832Not ApplicableCompletedPrimary

Reduction of Endometritis After Cesarean Section With the Routine Use of Methergine

NCT00386477Not ApplicableTerminated

Vaginal Cleansing at Cesarean Delivery to Reduce Infection: A Randomized, Controlled Trial

Scroll to load more

Research Network

Activity Timeline